Poster

Leveraging Generative AI To Design Novel, Functional Deaminases For Adenine Base Editing

Source: ElevateBio

By Matt Nethery, Principal Data Scientist, Computational Biology

GettyImages-934255454-compliance-regulatory-regulation-technology-digital-ai

Generative artificial intelligence and machine learning models offer a powerful path to transcend the evolutionary limits of natural protein sequence space. Training computational models on massive datasets of carefully filtered and structural-validated sequences enables the de novo creation of novel adenine deaminases. Selecting optimal sampling parameters balances generative creativity with structural integrity, producing diverse enzymes with low sequence identity to known wildtype variants. Iterative machine learning optimization rapidly improves baseline activity, driving adenine-to-guanine base editing performance from initial low single digits to over 20% on-target conversion. Crucially, these engineered candidates display exceptional specificity, yielding minimal bystander editing even at adjacent nucleotide positions.

Download the poster presentation to see how computational enzyme creation unlocks precise, tailor-made gene editing tools for previously intractable therapeutic targets.

access the Poster!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene